
Fuji Pharma Co Ltd
TSE:4554

Intrinsic Value
The intrinsic value of one
Fuji Pharma Co Ltd
stock under the Base Case scenario is
2 076.6
JPY.
Compared to the current market price of 1 389 JPY,
Fuji Pharma Co Ltd
is
Undervalued by 33%.
The Intrinsic Value is calculated as the average of DCF and Relative values:

Valuation History
Fuji Pharma Co Ltd
Fundamental Analysis


Revenue & Expenses Breakdown
Fuji Pharma Co Ltd
Balance Sheet Decomposition
Fuji Pharma Co Ltd
Current Assets | 45.6B |
Cash & Short-Term Investments | 3.7B |
Receivables | 20.1B |
Other Current Assets | 21.8B |
Non-Current Assets | 48.7B |
Long-Term Investments | 8.7B |
PP&E | 20.9B |
Intangibles | 12.2B |
Other Non-Current Assets | 6.8B |
Free Cash Flow Analysis
Fuji Pharma Co Ltd
JPY | |
Free Cash Flow | JPY |
Earnings Waterfall
Fuji Pharma Co Ltd
Revenue
|
48.4B
JPY
|
Cost of Revenue
|
-28.8B
JPY
|
Gross Profit
|
19.6B
JPY
|
Operating Expenses
|
-14.3B
JPY
|
Operating Income
|
5.3B
JPY
|
Other Expenses
|
-874m
JPY
|
Net Income
|
4.4B
JPY
|
Profitability Score
Profitability Due Diligence
Fuji Pharma Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.

Score
Fuji Pharma Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Fuji Pharma Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.

Score
Fuji Pharma Co Ltd's solvency score is 61/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Fuji Pharma Co Ltd
According to Wall Street analysts, the average 1-year price target for
Fuji Pharma Co Ltd
is 2 330.7 JPY
with a low forecast of 2 020 JPY and a high forecast of 2 698.5 JPY.
Dividends
Current shareholder yield for Fuji Pharma Co Ltd is
.
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one
Fuji Pharma Co Ltd
stock under the Base Case scenario is
2 076.6
JPY.
Compared to the current market price of 1 389 JPY,
Fuji Pharma Co Ltd
is
Undervalued by 33%.